TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Life Genomics AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
2,701
|
4,116
|
12,009 |
Financial expenses |
0
|
8
|
0 |
Earnings before taxes |
-466
|
-2,723
|
5,240 |
EBITDA |
-445
|
-2,212
|
5,525 |
Total assets |
2,332
|
3,896
|
6,715 |
Current assets |
2,222
|
3,748
|
4,478 |
Current liabilities |
481
|
1,586
|
1,391 |
Equity capital |
1,850
|
2,310
|
5,042 |
- share capital |
41
![]() |
41
|
44 |
Employees (average) |
10
|
18
|
23 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
79.3%
|
59.3%
|
75.1% |
Turnover per employee |
270
|
229
|
522 |
Profit as a percentage of turnover |
-17.3%
|
-66.2%
|
43.6% |
Return on assets (ROA) |
-20.0%
|
-69.7%
|
78.0% |
Current ratio |
462.0%
|
236.3%
|
321.9% |
Return on equity (ROE) |
-25.2%
|
-117.9%
|
103.9% |
Change turnover |
-1,426
|
-6,920
|
9,734 |
Change turnover % |
-35%
|
-63%
|
428% |
Chg. No. of employees |
-8
|
-5
|
17 |
Chg. No. of employees % |
-44%
|
-22%
|
283% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.